Hub : Traits :

Alcohol usually taken with meals

77 significantly associated models · 28 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 43073464 44618031 4 1 6.7e-09 8.9e-08 1.4e-01 92 HYI
2 1 150415631 151793174 2 1 5.6e-08 1.1e-06 7.4e-01 100 BNIPL
3 1 173103273 175663031 9 1 1.6e-10 1.2e-10 3.3e-02 89 ZBTB37
4 1 235988566 237463399 4 1 1.2e-09 3.5e-10 8.9e-02 93 RP11-385F5.4
5 3 70757099 71880670 1 1 3.0e-07 2.4e-09 2.5e-05 50 FOXP1
6 4 41746460 42336312 1 1 2.4e-07 1.2e-08 1.2e-02 81 SLC30A9
7 7 116660803 118207833 1 2 4.5e-08 1.3e-07 7.6e-01 100 CTTNBP2
8 11 56666189 58284951 3 2 2.3e-08 1.1e-07 1.0e+00 100 CTNND1 ZDHHC5
9 17 1588930 3000009 2 1 1.1e-09 8.1e-09 7.6e-02 91 RP1-59D14.1
10 18 34614002 35378540 1 1 9.0e-08 6.8e-07 1.1e-01 90 CELF4

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Bipolar Disorder or Schizophrenia 1.62 1 0 0.0 0.00 1.0e+00 HYI
Depressed Affect (Nagel 2018) 4.93 6 1 2.2 -0.74 5.8e-02 CELF4 CTTNBP2 RP1-59D14.1 SLC30A9 ZBTB37 ZDHHC5
Depression (Nagel 2018) 4.28 1 1 2.2 0.00 1.0e+00 ZDHHC5
Intelligence (Savage-Jansen 2018) 3.16 4 1 2.2 0.99 1.5e-02 FOXP1 HYI ZBTB37 ZDHHC5
Neuroticism (Nagel 2018) 6.84 6 3 6.7 -0.68 9.6e-02 CELF4 CTTNBP2 RP1-59D14.1 SLC30A9 ZBTB37 ZDHHC5
Schizophrenia (2018) 2.64 3 0 0.0 0.00 1.0e+00 FOXP1 HYI ZDHHC5
Schizophrenia vs Biploar Disorder 3.79 2 0 0.0 0.00 1.0e+00 ZBTB37 ZDHHC5
Worry (Nagel 2018) 3.40 3 0 0.0 0.00 1.0e+00 SLC30A9 ZBTB37 ZDHHC5
Major Depression (MDD) 6.29 3 0 0.0 -0.57 4.3e-01 CTTNBP2 SLC30A9 ZDHHC5
Verbal and Numeric Reasoning (VNR) 2.88 3 1 2.2 0.00 1.0e+00 FOXP1 HYI ZDHHC5
Neuroticism (2016) 4.14 2 0 0.0 0.00 1.0e+00 CELF4 RP1-59D14.1
Schizophrenia (2014) 2.33 3 0 0.0 0.00 1.0e+00 FOXP1 HYI ZDHHC5
Blood Eosinophil Count 0.71 2 0 0.0 0.00 1.0e+00 CTNND1 ZDHHC5
Blood Platelet Count 1.66 3 3 6.7 0.00 1.0e+00 RP11-385F5.4 RP1-59D14.1 ZDHHC5
Blood Red Count 0.94 4 1 2.2 -0.10 9.0e-01 HYI RP1-59D14.1 ZBTB37 ZDHHC5
Blood White Count 0.82 2 0 0.0 0.00 1.0e+00 FOXP1 HYI
Heel T-Score 0.80 2 1 2.2 0.00 1.0e+00 RP1-59D14.1 ZDHHC5
BMI 1.58 2 1 2.2 0.00 1.0e+00 BNIPL FOXP1
Height 0.59 5 1 2.2 0.60 2.9e-01 CELF4 CTTNBP2 HYI SLC30A9 ZDHHC5
Systolic Blood Pressure 2.63 3 2 4.4 0.00 1.0e+00 CTNND1 HYI ZDHHC5
Smoking Status 5.44 3 1 2.2 -0.95 5.1e-02 CTTNBP2 FOXP1 ZBTB37
Allergy or Eczema 1.31 1 0 0.0 0.00 1.0e+00 SLC30A9
Cardiovascular Disease 1.24 2 0 0.0 0.00 1.0e+00 BNIPL HYI
Respiratory disease 1.98 1 0 0.0 0.00 1.0e+00 ZBTB37
Type 2 Diabetes (T2D) (2018) 1.85 1 0 0.0 0.00 1.0e+00 CTTNBP2
Lung FEV1/FVC ratio 1.53 2 1 2.2 0.00 1.0e+00 CTTNBP2 ZDHHC5
Lung FVC 2.04 2 1 2.2 0.00 1.0e+00 CTTNBP2 FOXP1
Neuroticism 7.17 7 2 4.4 -0.73 4.1e-02 CELF4 CTNND1 CTTNBP2 RP1-59D14.1 SLC30A9 ZBTB37 ZDHHC5
Chronotype (morning person) 1.89 2 0 0.0 0.00 1.0e+00 CTNND1 ZDHHC5
Hand grip strength (left) 1.48 2 0 0.0 0.00 1.0e+00 FOXP1 ZDHHC5
Number of treatments/medications taken 2.34 2 0 0.0 0.00 1.0e+00 FOXP1 ZBTB37
Sensitivity / hurt feelings 3.82 2 0 0.0 0.00 1.0e+00 CELF4 ZDHHC5
Frequency of depressed mood in last 2 weeks 4.71 2 0 0.0 0.00 1.0e+00 SLC30A9 ZDHHC5
Relative age of first facial hair 2.54 3 0 0.0 0.00 1.0e+00 BNIPL HYI ZBTB37
Systolic blood pressure, automated reading 2.39 3 0 0.0 0.00 1.0e+00 HYI RP11-385F5.4 ZDHHC5
Vitamin and mineral supplements 2.36 1 0 0.0 0.00 1.0e+00 SLC30A9
Supplements: Zinc 2.71 1 0 0.0 0.00 1.0e+00 SLC30A9
Medication: Metformin 2.02 1 0 0.0 0.00 1.0e+00 CTTNBP2
Pack years adult smoking proportion 4.48 2 0 0.0 0.00 1.0e+00 CELF4 RP1-59D14.1
Impedance of leg (right) 1.32 3 1 2.2 0.00 1.0e+00 BNIPL RP1-59D14.1 SLC30A9
Leg fat-free mass (left) 0.87 2 0 0.0 0.00 1.0e+00 BNIPL HYI
Trunk fat percentage 2.37 5 1 2.2 -0.98 4.0e-03 BNIPL FOXP1 RP1-59D14.1 SLC30A9 ZDHHC5
Hand grip strength (right) 1.13 1 0 0.0 0.00 1.0e+00 FOXP1
Townsend deprivation index at recruitment 3.67 2 0 0.0 0.00 1.0e+00 CTTNBP2 ZDHHC5
Current tobacco smoking 4.81 2 0 0.0 0.00 1.0e+00 CELF4 CTTNBP2
Fed-up feelings 6.38 3 2 4.4 -0.99 7.6e-03 CELF4 CTTNBP2 ZDHHC5
Frequency of unenthusiasm / disinterest in last 2 weeks 5.51 2 0 0.0 0.00 1.0e+00 CTTNBP2 ZDHHC5
Relative age voice broke 1.61 1 0 0.0 0.00 1.0e+00 BNIPL
Taking other prescription medications 1.92 1 0 0.0 0.00 1.0e+00 ZBTB37
Age when periods started (menarche) 2.47 2 1 2.2 0.00 1.0e+00 BNIPL HYI
High blood pressure 1.48 2 0 0.0 0.00 1.0e+00 BNIPL HYI
Hayfever, allergic rhinitis or eczema 1.28 1 0 0.0 0.00 1.0e+00 SLC30A9
Stomach or abdominal pain in last month 1.34 1 0 0.0 0.00 1.0e+00 FOXP1
Supplements: Glucosamine 2.80 1 0 0.0 0.00 1.0e+00 SLC30A9
Sitting height 1.21 2 2 4.4 0.00 1.0e+00 HYI ZDHHC5
High blood pressure (mother) 2.29 1 0 0.0 0.00 1.0e+00 HYI
Body mass index (BMI) 1.53 2 1 2.2 0.00 1.0e+00 BNIPL FOXP1
Impedance of leg (left) 1.36 3 1 2.2 0.00 1.0e+00 BNIPL RP1-59D14.1 SLC30A9
Leg predicted mass (left) 0.85 1 0 0.0 0.00 1.0e+00 BNIPL
Trunk fat mass 1.84 2 1 2.2 0.00 1.0e+00 BNIPL FOXP1
Waist circumference 1.31 2 1 2.2 0.00 1.0e+00 BNIPL FOXP1
Past tobacco smoking 2.73 2 0 0.0 0.00 1.0e+00 CTTNBP2 ZBTB37
Frequency of tenseness / restlessness in last 2 weeks 2.85 1 0 0.0 0.00 1.0e+00 ZBTB37
Forced vital capacity (FVC) 1.82 1 1 2.2 0.00 1.0e+00 FOXP1
Ever unenthusiastic/disinterested for a whole week 3.24 1 0 0.0 0.00 1.0e+00 SLC30A9
Qualifications: None of the above 5.47 4 1 2.2 -0.40 6.0e-01 CELF4 FOXP1 HYI ZDHHC5
Financial difficulties in last 2 years 3.86 1 0 0.0 0.00 1.0e+00 CTTNBP2
Allergy 1.10 1 0 0.0 0.00 1.0e+00 SLC30A9
Diabetes (self-reported) 2.29 1 0 0.0 0.00 1.0e+00 CTTNBP2
Fluid intelligence score 3.44 3 1 2.2 0.00 1.0e+00 FOXP1 HYI ZDHHC5
Neuroticism score 6.97 6 2 4.4 -0.73 6.1e-02 CELF4 CTTNBP2 RP1-59D14.1 SLC30A9 ZBTB37 ZDHHC5
Weight 1.17 3 1 2.2 0.00 1.0e+00 BNIPL FOXP1 HYI
Impedance of arm (right) 1.23 2 0 0.0 0.00 1.0e+00 BNIPL ZDHHC5
Arm fat percentage (right) 2.16 3 2 4.4 0.00 1.0e+00 BNIPL FOXP1 ZDHHC5
Trunk fat-free mass 1.11 3 0 0.0 0.00 1.0e+00 BNIPL ZBTB37 ZDHHC5
Hip circumference 1.14 1 0 0.0 0.00 1.0e+00 BNIPL
Alcohol intake versus 10 years previously 2.76 1 0 0.0 0.00 1.0e+00 FOXP1
Worrier / anxious feelings 3.22 1 1 2.2 0.00 1.0e+00 ZDHHC5
Frequency of tiredness / lethargy in last 2 weeks 6.38 5 2 4.4 -0.68 2.0e-01 CTNND1 RP1-59D14.1 SLC30A9 ZBTB37 ZDHHC5
Forced expiratory volume in 1-second (FEV1) 2.45 3 1 2.2 0.00 1.0e+00 CTTNBP2 FOXP1 ZDHHC5
Qualifications: A levels/AS levels or equivalent 4.21 5 0 0.0 0.99 8.5e-04 CELF4 CTTNBP2 FOXP1 HYI SLC30A9
Mouth/teeth dental problems: Dentures 1.83 1 0 0.0 0.00 1.0e+00 HYI
Asthma 1.53 1 0 0.0 0.00 1.0e+00 ZBTB37
Forced expiratory volume in 1-second (FEV1), Best measure 2.05 2 0 0.0 0.00 1.0e+00 FOXP1 ZDHHC5
Impedance of arm (left) 1.23 3 0 0.0 0.00 1.0e+00 BNIPL SLC30A9 ZDHHC5
Arm fat mass (right) 1.72 2 1 2.2 0.00 1.0e+00 BNIPL FOXP1
Trunk predicted mass 1.09 3 0 0.0 0.00 1.0e+00 BNIPL ZBTB37 ZDHHC5
Standing height 0.59 2 0 0.0 0.00 1.0e+00 HYI ZDHHC5
Tense / 'highly strung' 2.81 2 0 0.0 0.00 1.0e+00 ZBTB37 ZDHHC5
Seen doctor (GP) for nerves, anxiety, tension or depression 5.01 3 0 0.0 -0.99 5.3e-03 CELF4 CTTNBP2 ZDHHC5
Peak expiratory flow (PEF) 2.31 2 0 0.0 0.00 1.0e+00 CTTNBP2 ZDHHC5
Qualifications: O levels/GCSEs or equivalent 2.74 1 0 0.0 0.00 1.0e+00 FOXP1
Medication: Paracetamol 2.52 1 0 0.0 0.00 1.0e+00 ZBTB37
Headache pain in last month 2.82 3 0 0.0 0.00 1.0e+00 FOXP1 ZBTB37 ZDHHC5
Forced vital capacity (FVC), Best measure 1.48 1 1 2.2 0.00 1.0e+00 FOXP1
Body fat percentage 2.53 4 1 2.2 -0.98 1.9e-02 BNIPL FOXP1 RP1-59D14.1 ZDHHC5
Leg fat percentage (right) 2.55 3 1 2.2 0.00 1.0e+00 BNIPL FOXP1 RP1-59D14.1
Arm fat-free mass (right) 1.10 2 1 2.2 0.00 1.0e+00 BNIPL ZDHHC5
Exposure to tobacco smoke outside home 3.69 1 1 2.2 0.00 1.0e+00 CTTNBP2
Comparative body size at age 10 1.55 1 0 0.0 0.00 1.0e+00 SLC30A9
Worry too long after embarrassment 6.32 3 2 4.4 0.00 1.0e+00 CTTNBP2 RP1-59D14.1 ZDHHC5
Seen a psychiatrist for nerves, anxiety, tension or depression 3.02 1 0 0.0 0.00 1.0e+00 CTTNBP2
Wheeze or whistling in the chest in last year 2.54 2 0 0.0 0.00 1.0e+00 CELF4 ZBTB37
Age at first live birth 2.65 1 0 0.0 0.00 1.0e+00 CELF4
Qualifications: College or University degree 6.03 8 3 6.7 0.98 2.1e-05 BNIPL CELF4 CTTNBP2 FOXP1 HYI RP1-59D14.1 ZBTB37 ZDHHC5
Medication for pain relief, constipation, heartburn 2.41 1 0 0.0 0.00 1.0e+00 ZBTB37
Mean time to correctly identify matches 1.59 1 0 0.0 0.00 1.0e+00 CELF4
Whole body fat mass 1.86 2 1 2.2 0.00 1.0e+00 BNIPL FOXP1
Leg fat mass (right) 1.96 3 1 2.2 0.00 1.0e+00 BNIPL FOXP1 RP1-59D14.1
Arm predicted mass (right) 1.03 1 1 2.2 0.00 1.0e+00 BNIPL
Pulse rate, automated reading 2.86 4 1 2.2 -0.53 4.7e-01 HYI RP1-59D14.1 ZBTB37 ZDHHC5
Alcohol intake frequency. 3.97 3 1 2.2 0.00 1.0e+00 CTNND1 FOXP1 ZDHHC5
Comparative height size at age 10 0.95 1 1 2.2 0.00 1.0e+00 HYI
Overall health rating 4.97 4 2 4.4 -0.99 1.3e-02 FOXP1 RP1-59D14.1 ZBTB37 ZDHHC5
Illness, injury, bereavement, stress in last 2 years 3.02 1 0 0.0 0.00 1.0e+00 CTTNBP2
Hypertension (Self-reported) 1.28 2 0 0.0 0.00 1.0e+00 BNIPL HYI
Whole body fat-free mass 0.99 2 0 0.0 0.00 1.0e+00 BNIPL ZBTB37
Leg fat-free mass (right) 0.81 1 0 0.0 0.00 1.0e+00 BNIPL
Arm fat percentage (left) 2.17 3 2 4.4 0.00 1.0e+00 BNIPL FOXP1 ZDHHC5
Average weekly red wine intake 10.60 5 3 6.7 0.97 7.8e-03 CTNND1 FOXP1 RP11-385F5.4 RP1-59D14.1 ZDHHC5
Mood swings 4.24 2 0 0.0 0.00 1.0e+00 CELF4 CTTNBP2
Loneliness, isolation 3.24 1 0 0.0 0.00 1.0e+00 ZDHHC5
Long-standing illness, disability or infirmity 2.50 1 0 0.0 0.00 1.0e+00 FOXP1
Qualifications: nursing, teaching 3.55 1 0 0.0 0.00 1.0e+00 ZDHHC5
Mineral and other dietary supplements 2.94 1 0 0.0 0.00 1.0e+00 SLC30A9
Asthma (self-reported) 1.44 1 0 0.0 0.00 1.0e+00 ZBTB37
Smoking status: Current 4.26 2 0 0.0 0.00 1.0e+00 CELF4 CTTNBP2
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.91 1 0 0.0 0.00 1.0e+00 FOXP1
Whole body water mass 0.98 2 0 0.0 0.00 1.0e+00 BNIPL ZBTB37
Leg predicted mass (right) 0.84 1 0 0.0 0.00 1.0e+00 BNIPL
Arm fat mass (left) 1.78 2 1 2.2 0.00 1.0e+00 BNIPL FOXP1
Miserableness 4.52 3 0 0.0 0.00 1.0e+00 CELF4 CTTNBP2 ZBTB37
Guilty feelings 4.77 2 0 0.0 0.00 1.0e+00 CTTNBP2 ZDHHC5
Mother's age at death 2.06 1 0 0.0 0.00 1.0e+00 CTNND1
Pain type(s) experienced in last month: Hip pain 1.63 1 0 0.0 0.00 1.0e+00 FOXP1
Supplements: Fish oil (including cod liver oil) 2.14 1 0 0.0 0.00 1.0e+00 SLC30A9
Medication: Paracetamol 2.61 1 0 0.0 0.00 1.0e+00 ZBTB37
Ever smoked 3.96 1 1 2.2 0.00 1.0e+00 CTTNBP2
Basal metabolic rate 0.93 2 1 2.2 0.00 1.0e+00 BNIPL ZBTB37
Leg fat percentage (left) 2.45 3 2 4.4 0.00 1.0e+00 BNIPL FOXP1 RP1-59D14.1
Arm fat-free mass (left) 1.10 2 1 2.2 0.00 1.0e+00 BNIPL ZBTB37
Average weekly beer plus cider intake 5.12 2 0 0.0 0.00 1.0e+00 CELF4 CTTNBP2
Irritability 3.21 1 0 0.0 0.00 1.0e+00 CELF4
Fractured/broken bones in last 5 years 2.19 1 0 0.0 0.00 1.0e+00 CTTNBP2
Diastolic blood pressure, automated reading 1.14 1 0 0.0 0.00 1.0e+00 HYI
Unable to work because of sickness or disability 3.77 1 0 0.0 0.00 1.0e+00 ZDHHC5
Commuting to job workplace: Cycle 4.00 2 0 0.0 0.00 1.0e+00 FOXP1 RP1-59D14.1
Vascular/heart problems diagnosed by doctor 1.52 2 0 0.0 0.00 1.0e+00 BNIPL HYI
Pain experienced in last month 3.14 2 0 0.0 0.00 1.0e+00 FOXP1 ZBTB37
Pack years of smoking 4.31 2 0 0.0 0.00 1.0e+00 CELF4 RP1-59D14.1
Impedance of whole body 1.33 3 0 0.0 0.00 1.0e+00 BNIPL RP1-59D14.1 SLC30A9
Leg fat mass (left) 1.92 3 1 2.2 0.00 1.0e+00 BNIPL FOXP1 RP1-59D14.1
Arm predicted mass (left) 1.13 2 1 2.2 0.00 1.0e+00 BNIPL ZBTB37

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 2 0.057 1.6
GTEx Adipose Visceral Omentum 2 0.098 1.7
GTEx Adrenal Gland 1 0.069 1.7
GTEx Artery Aorta 0 0.000 1.6
GTEx Artery Coronary 0 0.000 1.6
GTEx Artery Tibial 1 0.027 1.7
GTEx Brain Caudate basal ganglia 2 0.217 1.7
GTEx Brain Cerebellar Hemisphere 1 0.067 1.7
GTEx Brain Cerebellum 0 0.000 1.6
GTEx Brain Cortex 0 0.000 1.6
GTEx Brain Frontal Cortex BA9 0 0.000 1.6
GTEx Brain Hippocampus 0 0.000 1.4
GTEx Brain Hypothalamus 0 0.000 1.6
GTEx Brain Nucleus accumbens basal ganglia 1 0.116 1.6
GTEx Brain Putamen basal ganglia 0 0.000 1.7
GTEx Breast Mammary Tissue 2 0.101 1.7
GTEx Breast Mammary Tissue (Male) 0 0.000 1.6
GTEx Breast Mammary Tissue (Female) 1 0.061 1.6
GTEx Cells EBV-transformed lymphocytes 2 0.141 1.6
GTEx Cells Transformed fibroblasts 4 0.095 1.6
GTEx Colon Sigmoid 0 0.000 1.7
GTEx Colon Transverse 2 0.097 1.6
GTEx Esophagus Gastroesophageal Junction 0 0.000 1.6
GTEx Esophagus Mucosa 1 0.030 1.7
GTEx Esophagus Muscularis 1 0.031 1.7
GTEx Heart Atrial Appendage 0 0.000 1.7
GTEx Heart Left Ventricle 2 0.131 1.7
GTEx Liver 0 0.000 1.5
GTEx Lung 5 0.174 1.7
GTEx Muscle Skeletal 0 0.000 1.7
GTEx Nerve Tibial 1 0.023 1.6
GTEx Ovary 0 0.000 1.6
GTEx Pancreas 1 0.061 1.7
GTEx Pituitary 0 0.000 1.5
GTEx Prostate 0 0.000 1.5
GTEx Skin Not Sun Exposed Suprapubic 3 0.122 1.7
GTEx Skin Sun Exposed Lower leg 4 0.110 1.6
GTEx Small Intestine Terminal Ileum 0 0.000 1.6
GTEx Spleen 0 0.000 1.6
GTEx Stomach 2 0.138 1.7
GTEx Testis 2 0.063 1.6
GTEx Thyroid 2 0.050 1.7
GTEx Uterus 0 0.000 1.5
GTEx Vagina 0 0.000 1.9
GTEx Whole Blood 0 0.000 1.6
METSIM Adipose 2 0.043 1.5
NTR Blood 2 0.083 1.6
ROSMAP Brain Pre-frontal Cortex 2 0.046 1.7
YFS Blood 2 0.043 1.6
CommonMind Brain Pre-frontal Cortex 4 0.074 1.7
The Cancer Genome Atlas Bladder Urothelial Carcinoma 3 0.181 1.7
The Cancer Genome Atlas Breast Invasive Carcinoma 2 0.045 1.6
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 0 0.000 1.6
The Cancer Genome Atlas Colon Adenocarcinoma 0 0.000 1.6
The Cancer Genome Atlas Esophageal Carcinoma 1 0.146 1.7
The Cancer Genome Atlas Glioblastoma Multiforme 0 0.000 1.5
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 1 0.037 1.6
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 0 0.000 1.6
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 1 0.049 1.6
The Cancer Genome Atlas Brain Lower Grade Glioma 4 0.093 1.7
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 0 0.000 1.6
The Cancer Genome Atlas Lung Adenocarcinoma 1 0.034 1.7
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 1 0.040 1.6
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 0 0.000 1.5
The Cancer Genome Atlas Pancreatic Adenocarcinoma 0 0.000 1.6
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 0 0.000 1.6
The Cancer Genome Atlas Prostate Adenocarcinoma 1 0.022 1.6
The Cancer Genome Atlas Rectum Adenocarcinoma 1 0.145 1.5
The Cancer Genome Atlas Soft Tissue Sarcoma 1 0.094 1.6
The Cancer Genome Atlas Skin Cutaneous Melanoma 0 0.000 1.6
The Cancer Genome Atlas Stomach Adenocarcinoma 0 0.000 1.6
The Cancer Genome Atlas Testicular Germ Cell Tumors 1 0.078 1.6
The Cancer Genome Atlas Thyroid Carcinoma 2 0.039 1.6
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 0 0.000 1.5